Zobrazeno 1 - 10
of 1 528
pro vyhledávání: '"Vlachogiannis, G."'
Autor:
Hedayat S; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom., Cascione L; Bioinformatics Core Unit, Institute of Oncology Research (IOR), Faculty of Biomedical Sciences, Università della Svizzera italiana, Bellinzona, Switzerland.; Swiss Institute of Bioinformatics, Bellinzona, Switzerland., Cunningham D; Department of Medicine, The Royal Marsden Hospital, London and Sutton, United Kingdom., Schirripa M; Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy., Lampis A; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom., Hahne JC; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom., Tunariu N; Department of Radiology, The Royal Marsden Hospital, London and Sutton, United Kingdom., Hong SP; Division of Surgery and Cancer, Imperial College London, London, United Kingdom., Marchetti S; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom., Khan K; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Department of Medicine, The Royal Marsden Hospital, London and Sutton, United Kingdom., Fontana E; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom., Angerilli V; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Department of Medicine, Surgical Pathology Unit, University of Padua, Padua, Italy., Delrieux M; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom., Nava Rodrigues D; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom., Procaccio L; Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy., Rao S; Department of Medicine, The Royal Marsden Hospital, London and Sutton, United Kingdom., Watkins D; Department of Medicine, The Royal Marsden Hospital, London and Sutton, United Kingdom., Starling N; Department of Medicine, The Royal Marsden Hospital, London and Sutton, United Kingdom., Chau I; Department of Medicine, The Royal Marsden Hospital, London and Sutton, United Kingdom., Braconi C; Department of Medicine, The Royal Marsden Hospital, London and Sutton, United Kingdom.; Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom.; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Fotiadis N; Department of Interventional Radiology, The Royal Marsden Hospital, London, United Kingdom., Begum R; Department of Medicine, The Royal Marsden Hospital, London and Sutton, United Kingdom., Guppy N; Breast Cancer Now Nina Barough Pathology Core Facility, The Institute of Cancer Research, London, United Kingdom., Howell L; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom., Valenti M; Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom., Cribbes S; Revvity, Waltham, Massachusetts., Kolozsvari B; Sartorius, London, United Kingdom., Kirkin V; Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom., Lonardi S; Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy., Ghidini M; Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Passalacqua R; Oncology Unit, ASST Cremona, Cremona, Italy., Elghadi R; Division of Surgery and Cancer, Imperial College London, London, United Kingdom., Magnani L; Division of Surgery and Cancer, Imperial College London, London, United Kingdom., Pinato DJ; Division of Surgery and Cancer, Imperial College London, London, United Kingdom.; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Di Maggio F; Division of Surgery and Cancer, Imperial College London, London, United Kingdom.; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy.; CEINGE-Biotecnologie Avanzate Francesco Salvatore, Via Gaetano Salvatore, Naples, Italy., Ghelardi F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Sottotetti E; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Vetere G; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Ciracì P; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Vlachogiannis G; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Division of Surgery and Cancer, Imperial College London, London, United Kingdom., Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cremolini C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Cortellini A; Division of Surgery and Cancer, Imperial College London, London, United Kingdom.; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy., Loupakis F; Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy., Fassan M; Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy.; Department of Medicine, Surgical Pathology Unit, University of Padua, Padua, Italy., Valeri N; Division of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Department of Medicine, The Royal Marsden Hospital, London and Sutton, United Kingdom.; Division of Surgery and Cancer, Imperial College London, London, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 15; Vol. 30 (10), pp. 2140-2159.
Autor:
Giamarellos-Bourboulis, E.J., Tsaganos, T., Tsangaris, I., Lada, M., Routsi, C., Sinapidis, D., Koupetori, M., Bristianou, M., Adamis, G., Mandragos, K., Dalekos, G.N., Kritselis, I., Giannikopoulos, G., Koutelidakis, I., Pavlaki, M., Antoniadou, E., Vlachogiannis, G., Koulouras, V., Prekates, A., Dimopoulos, G., Koutsoukou, A., Pnevmatikos, I., Ioakeimidou, A., Kotanidou, A., Orfanos, S.E., Armaganidis, A., Gogos, C.
Publikováno v:
In Clinical Microbiology and Infection February 2017 23(2):104-109
Autor:
Giamarellos-Bourboulis, E.J., Tziolos, N., Routsi, C., Katsenos, C., Tsangaris, I., Pneumatikos, I., Vlachogiannis, G., Theodorou, V., Prekates, A., Antypa, E., Koulouras, V., Kapravelos, N., Gogos, C., Antoniadou, E., Mandragos, K., Armaganidis, A.
Publikováno v:
In Clinical Microbiology and Infection June 2016 22(6):499-506
Autor:
Lote H; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.; Department of Gastrointestinal Oncology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom., Mousoullou F; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom., Vlachogiannis G; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Lampis A; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Satchwell L; Department of Gastrointestinal Oncology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom., Peckitt C; Department of Gastrointestinal Oncology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom., Fong C; Department of Gastrointestinal Oncology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom., Begum R; Department of Gastrointestinal Oncology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom., Kidd S; Department of Gastrointestinal Oncology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom., Cromarty S; Department of Gastrointestinal Oncology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom., Gordon A; Department of Gastrointestinal Oncology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom., Fribbens C; Department of Gastrointestinal Oncology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom., Rao S; Department of Gastrointestinal Oncology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom., Starling N; Department of Gastrointestinal Oncology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom., Chau I; Department of Gastrointestinal Oncology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom., Cunningham D; Department of Gastrointestinal Oncology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom., Valeri N; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 Nov 29; Vol. 13, pp. 1258365. Date of Electronic Publication: 2023 Nov 29 (Print Publication: 2023).
Autor:
Lampis A; Division of Molecular Pathology, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK., Hahne JC; Division of Molecular Pathology, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK., Gasparini P; Department of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH, USA.; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, NSW, Australia.; Hunter Medical Research Institute, New Lambton Heights, NSW, Australia., Cascione L; Bioinformatics Core Unit, Institute of Oncology Research (IOR), Faculty of Biomedical Sciences, Università della Svizzera italiana, Bellinzona, Switzerland.; Swiss Institute of Bioinformatics, Bellinzona, Switzerland., Hedayat S; Division of Molecular Pathology, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK., Vlachogiannis G; Division of Molecular Pathology, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK., Murgia C; Cancer Research UK Beatson Institute, Glasgow, UK., Fontana E; Division of Molecular Pathology, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK., Edwards J; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Horgan PG; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Terracciano L; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; IRCCS Humanitas Research Hospital, Milan, Italy., Sansom OJ; Cancer Research UK Beatson Institute, Glasgow, UK.; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Martins CD; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Kramer-Marek G; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Croce CM; Department of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH, USA., Braconi C; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Fassan M; IRCCS Humanitas Research Hospital, Milan, Italy.; Department of Medicine, Surgical Pathology Unit, University of Padua, Padua, Italy.; Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy., Valeri N; Division of Molecular Pathology, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. nicola.valeri@icr.ac.uk.; Department of Medicine, The Royal Marsden Hospital, London, UK. nicola.valeri@icr.ac.uk.; Division of Surgery and Cancer, Imperial College London, London, UK. nicola.valeri@icr.ac.uk.
Publikováno v:
Cell death and differentiation [Cell Death Differ] 2021 Oct; Vol. 28 (10), pp. 2970-2982. Date of Electronic Publication: 2021 Jul 05.
Autor:
Novellasdemunt L; Stem Cell and Cancer Biology Laboratory, the Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Kucharska A; Stem Cell and Cancer Biology Laboratory, the Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Baulies A; Stem Cell and Cancer Biology Laboratory, the Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Hutton C; Stem Cell and Cancer Biology Laboratory, the Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Vlachogiannis G; Centre for Molecular Pathology, the Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK., Repana D; Cancer Systems Biology Laboratory, the Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Rowan A; Cancer Evolution and Genome Instability Laboratory, the Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Suárez-Bonnet A; Pathobiology and Population Sciences, Royal Veterinary College, Hatfield AL9 7TA, UK; Experimental Histopathology, the Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Ciccarelli F; Cancer Systems Biology Laboratory, the Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Valeri N; Centre for Molecular Pathology, the Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK., Li VSW; Stem Cell and Cancer Biology Laboratory, the Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK. Electronic address: vivian.li@crick.ac.uk.
Publikováno v:
Stem cell reports [Stem Cell Reports] 2023 Feb 14; Vol. 18 (2), pp. 570-584. Date of Electronic Publication: 2023 Jan 19.
Autor:
Colyn L; Hepatology Program, CIMA, Universidad de Navarra, Pamplona, Spain., Alvarez-Sola G; Hepatology Program, CIMA, Universidad de Navarra, Pamplona, Spain.; CIBERehd, Madrid, Spain., Latasa MU; Hepatology Program, CIMA, Universidad de Navarra, Pamplona, Spain.; Instituto de Investigaciones Sanitarias de Navarra IdiSNA, Pamplona, Spain., Uriarte I; Hepatology Program, CIMA, Universidad de Navarra, Pamplona, Spain.; CIBERehd, Madrid, Spain., Herranz JM; Hepatology Program, CIMA, Universidad de Navarra, Pamplona, Spain.; CIBERehd, Madrid, Spain., Arechederra M; Hepatology Program, CIMA, Universidad de Navarra, Pamplona, Spain.; CIBERehd, Madrid, Spain.; Instituto de Investigaciones Sanitarias de Navarra IdiSNA, Pamplona, Spain., Vlachogiannis G; Division of Surgery and Cancer, Imperial College London, London, UK., Rae C; Institute of Cancer Sciences, The University of Glasgow, Glasgow, UK., Pineda-Lucena A; Molecular Therapies Program, CIMA, Universidad de Navarra, Pamplona, Spain., Casadei-Gardini A; Department of Oncology, San Raffaele Hospital, Milan, Italy., Pedica F; Department of Experimental Oncology, Pathology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Aldrighetti L; Hepatobiliary Surgery Division, Vita-Salute San Raffaele University, IRCCS San Raffaele Hospital, Milan, Italy., López-López A; Centro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia University San Pablo CEU, Boadilla del Monte, Spain., López-Gonzálvez A; Centro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia University San Pablo CEU, Boadilla del Monte, Spain., Barbas C; Centro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia University San Pablo CEU, Boadilla del Monte, Spain., Ciordia S; Functional Proteomics Laboratory, CNB-CSIC, Proteored-ISCIII, Madrid, Spain., Van Liempd SM; Exosomes Laboratory and Metabolomics Platform, CIC bioGUNE-BRTA, Derio, Spain., Falcón-Pérez JM; CIBERehd, Madrid, Spain.; Exosomes Laboratory and Metabolomics Platform, CIC bioGUNE-BRTA, Derio, Spain.; Ikerbaske, Basque Foundation for Science, Bilbao, Spain., Urman J; Instituto de Investigaciones Sanitarias de Navarra IdiSNA, Pamplona, Spain.; Gastroenterology Department, Hospital Universitario de Navarra, Pamplona, Spain., Sangro B; CIBERehd, Madrid, Spain.; Instituto de Investigaciones Sanitarias de Navarra IdiSNA, Pamplona, Spain.; Hepatology Unit, Clínica Universidad de Navarra, Pamplona, Spain., Vicent S; Instituto de Investigaciones Sanitarias de Navarra IdiSNA, Pamplona, Spain.; Solid Tumors Program, CIMA, Universidad de Navarra, Pamplona, Spain.; CIBERonc, Madrid, Spain., Iraburu MJ; Department of Biochemistry and Genetics, University of Navarra, Pamplona, Spain., Prosper F; Oncohematology Program, CIMA, Universidad de Navarra, Pamplona, Spain., Nelson LJ; Institute of Engineering, School of Engineering, Faraday Building, The University of Edimburgh, Edinburgh, Scotland, UK., Banales JM; CIBERehd, Madrid, Spain.; Department of Biochemistry and Genetics, University of Navarra, Pamplona, Spain.; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute - Donostia University Hospital, Ikerbasque, San Sebastian, Spain., Martinez-Chantar ML; CIBERehd, Madrid, Spain.; Liver Research Laboratory, CIC bioGUNE, Derio, Spain., Marin JJG; CIBERehd, Madrid, Spain.; Physiology and Pharmacology Department, HEVEPHARM, IBSAL, University of Salamanca, Salamanca, Spain., Braconi C; Institute of Cancer Sciences, The University of Glasgow, Glasgow, UK.; Beatson West of Scotland Cancer Center, Glasgow, UK., Trautwein C; Department of Internal Medicine III, University Hospital, RWTH Aachen, Aachen, Germany., Corrales FJ; CIBERehd, Madrid, Spain.; Functional Proteomics Laboratory, CNB-CSIC, Proteored-ISCIII, Madrid, Spain., Cubero FJ; CIBERehd, Madrid, Spain.; Department of Immunology, Ophthalmology and ENT, School of Medicine, Complutense University, Madrid, Spain., Berasain C; Hepatology Program, CIMA, Universidad de Navarra, Pamplona, Spain.; CIBERehd, Madrid, Spain.; Instituto de Investigaciones Sanitarias de Navarra IdiSNA, Pamplona, Spain., Fernandez-Barrena MG; Hepatology Program, CIMA, Universidad de Navarra, Pamplona, Spain.; CIBERehd, Madrid, Spain.; Instituto de Investigaciones Sanitarias de Navarra IdiSNA, Pamplona, Spain., Avila MA; Hepatology Program, CIMA, Universidad de Navarra, Pamplona, Spain. maavila@unav.es.; CIBERehd, Madrid, Spain. maavila@unav.es.; Instituto de Investigaciones Sanitarias de Navarra IdiSNA, Pamplona, Spain. maavila@unav.es.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2022 May 26; Vol. 41 (1), pp. 183. Date of Electronic Publication: 2022 May 26.
Autor:
Acar A; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Department of Biological Sciences, Middle East Technical University, Ankara, Turkey., Nichol D; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK., Fernandez-Mateos J; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK., Cresswell GD; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK., Barozzi I; Department of Surgery and Cancer, Imperial College London, London, UK., Hong SP; Department of Surgery and Cancer, Imperial College London, London, UK., Trahearn N; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK., Spiteri I; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK., Stubbs M; CRUK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK., Burke R; CRUK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK., Stewart A; Clinical Pharmacology-Adaptive Therapy Group, Division of Cancer Therapeutics and Clinical Studies, The Institute of Cancer Research, London, UK., Caravagna G; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK., Werner B; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK., Vlachogiannis G; Gastrointestinal Cancer Biology and Genomics Team, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK., Maley CC; Arizona Cancer Evolution Center, Biodesign Institute, Arizona State University, Tempe, USA., Magnani L; Department of Surgery and Cancer, Imperial College London, London, UK., Valeri N; Gastrointestinal Cancer Biology and Genomics Team, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK., Banerji U; CRUK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK. udai.banerji@icr.ac.uk.; Clinical Pharmacology-Adaptive Therapy Group, Division of Cancer Therapeutics and Clinical Studies, The Institute of Cancer Research, London, UK. udai.banerji@icr.ac.uk.; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden Hospital NHS Foundation Trust, London, UK. udai.banerji@icr.ac.uk., Sottoriva A; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. andrea.sottoriva@icr.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2020 Apr 21; Vol. 11 (1), pp. 1923. Date of Electronic Publication: 2020 Apr 21.
Autor:
Schmidt S; Theodor Boveri Institute, Biocenter, University of Würzburg, Am Hubland, Würzburg, Germany.; Department of General, Visceral, Vascular and Pediatric Surgery, University Hospital Würzburg, Würzburg, Germany., Gay D; CRUK Beatson Institute, Glasgow, UK., Uthe FW; Theodor Boveri Institute, Biocenter, University of Würzburg, Am Hubland, Würzburg, Germany.; Department of General, Visceral, Vascular and Pediatric Surgery, University Hospital Würzburg, Würzburg, Germany., Denk S; Theodor Boveri Institute, Biocenter, University of Würzburg, Am Hubland, Würzburg, Germany.; Department of General, Visceral, Vascular and Pediatric Surgery, University Hospital Würzburg, Würzburg, Germany., Paauwe M; CRUK Beatson Institute, Glasgow, UK., Matthes N; Theodor Boveri Institute, Biocenter, University of Würzburg, Am Hubland, Würzburg, Germany.; Department of General, Visceral, Vascular and Pediatric Surgery, University Hospital Würzburg, Würzburg, Germany., Diefenbacher ME; Theodor Boveri Institute, Biocenter, University of Würzburg, Am Hubland, Würzburg, Germany., Bryson S; CRUK Beatson Institute, Glasgow, UK., Warrander FC; CRUK Beatson Institute, Glasgow, UK., Erhard F; Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany., Ade CP; Theodor Boveri Institute, Biocenter, University of Würzburg, Am Hubland, Würzburg, Germany., Baluapuri A; Theodor Boveri Institute, Biocenter, University of Würzburg, Am Hubland, Würzburg, Germany., Walz S; Comprehensive Cancer Center Mainfranken, Core Unit Bioinformatics, Biocenter, University of Würzburg, Am Hubland, Würzburg, Germany., Jackstadt R; CRUK Beatson Institute, Glasgow, UK., Ford C; CRUK Beatson Institute, Glasgow, UK., Vlachogiannis G; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Valeri N; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.; Department of Medicine, The Royal Marsden NHS Trust, London, UK., Otto C; Department of General, Visceral, Vascular and Pediatric Surgery, University Hospital Würzburg, Würzburg, Germany., Schülein-Völk C; Theodor Boveri Institute, Biocenter, University of Würzburg, Am Hubland, Würzburg, Germany., Maurus K; Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany., Schmitz W; Theodor Boveri Institute, Biocenter, University of Würzburg, Am Hubland, Würzburg, Germany., Knight JRP; CRUK Beatson Institute, Glasgow, UK., Wolf E; Theodor Boveri Institute, Biocenter, University of Würzburg, Am Hubland, Würzburg, Germany., Strathdee D; CRUK Beatson Institute, Glasgow, UK., Schulze A; Theodor Boveri Institute, Biocenter, University of Würzburg, Am Hubland, Würzburg, Germany.; Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany., Germer CT; Department of General, Visceral, Vascular and Pediatric Surgery, University Hospital Würzburg, Würzburg, Germany.; Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany., Rosenwald A; Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany., Sansom OJ; CRUK Beatson Institute, Glasgow, UK.; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Eilers M; Theodor Boveri Institute, Biocenter, University of Würzburg, Am Hubland, Würzburg, Germany. martin.eilers@biozentrum.uni-wuerzburg.de.; Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany. martin.eilers@biozentrum.uni-wuerzburg.de., Wiegering A; Theodor Boveri Institute, Biocenter, University of Würzburg, Am Hubland, Würzburg, Germany. wiegering_a@ukw.de.; Department of General, Visceral, Vascular and Pediatric Surgery, University Hospital Würzburg, Würzburg, Germany. wiegering_a@ukw.de.; Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany. wiegering_a@ukw.de.
Publikováno v:
Nature cell biology [Nat Cell Biol] 2019 Nov; Vol. 21 (11), pp. 1413-1424. Date of Electronic Publication: 2019 Nov 04.
Objectives Sepsis-3 definitions generated controversies regarding their general applicability. The Sepsis-3 Task Force outlined the need for validation with emphasis on the quick Sequential Organ Failure Assessment (qSOFA) score. This was done in a p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::cd900042867122c32bebd90f3a677da5
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3108926
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3108926